Stem Cells and Cloning-Advances and Applications

Scope & Guideline

Fostering Collaboration in Cutting-Edge Research

Introduction

Explore the comprehensive scope of Stem Cells and Cloning-Advances and Applications through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Stem Cells and Cloning-Advances and Applications in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1178-6957
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2010 to 2024
AbbreviationSTEM CELLS CLONING / Stem Cells Cloning
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Stem Cells and Cloning: Advances and Applications' focuses on the multifaceted research surrounding stem cells and their applications in regenerative medicine, cloning, and therapeutic strategies. The journal aims to disseminate knowledge about innovative methodologies and findings in this rapidly evolving field.
  1. Stem Cell Biology and Mechanisms:
    Research on the fundamental biology of various types of stem cells, including embryonic, induced pluripotent, and adult stem cells, focusing on their mechanisms of self-renewal, differentiation, and therapeutic potentials.
  2. Clinical Applications of Stem Cells:
    Exploration of the therapeutic applications of stem cells in treating a range of conditions, including neurological disorders, cardiovascular diseases, and injuries, emphasizing clinical trials and patient outcomes.
  3. Tissue Engineering and Regenerative Medicine:
    Investigations into how stem cells can be used in tissue engineering, including the development of scaffolds and biomaterials that enhance stem cell functionality for tissue regeneration.
  4. Stem Cell Technologies and Methodologies:
    Development and refinement of methods for stem cell isolation, culture, and manipulation, including novel approaches like 3D culture systems and bioprinting.
  5. Stem Cells and Disease Modeling:
    Use of stem cells to model diseases in vitro, allowing for better understanding of disease mechanisms and the testing of therapeutic strategies.
Recent publications indicate several emerging themes and trends within the scope of stem cell research. These trends reflect the evolving landscape of the field, highlighting areas of increased interest and potential future directions.
  1. Exosome and Stem Cell Interaction:
    Research into the role of exosomes in stem cell therapy is gaining traction, as these extracellular vesicles are recognized for their ability to mediate communication and enhance therapeutic efficacy.
  2. Nanotechnology in Stem Cell Therapy:
    The application of nanotechnology, such as nanoparticles for drug delivery and therapeutic enhancement, is emerging as a promising area, particularly in improving stem cell therapy outcomes.
  3. Personalized Stem Cell Therapy:
    There is a growing trend towards personalized medicine approaches, focusing on tailoring stem cell therapies to individual patient profiles, which may improve treatment efficacy and safety.
  4. Stem Cells in Aging and Regeneration:
    Research on the role of stem cells in aging processes and their potential applications in anti-aging therapies is becoming increasingly relevant, as the global population ages.
  5. Interdisciplinary Approaches to Stem Cell Research:
    The integration of various scientific disciplines, such as bioinformatics and molecular biology, is emerging as a key trend, facilitating a more comprehensive understanding of stem cell behaviors and applications.

Declining or Waning

While the journal continues to thrive in many areas, certain themes appear to be less prominent in recent publications. This may reflect shifting research priorities or advancements in the field that render previous topics less relevant.
  1. Cloning Techniques and Applications:
    Research specifically focused on cloning methodologies and their applications has seen a decline, possibly due to ethical concerns and the increasing focus on stem cell therapies.
  2. Animal Models in Stem Cell Research:
    There has been a noticeable reduction in studies utilizing animal models for stem cell research, as there is a growing emphasis on human-derived stem cells and in vitro models that better represent human biology.
  3. Basic Studies on Stem Cell Properties:
    While foundational research is still critical, there is a shift away from purely basic studies of stem cell properties towards applied research that emphasizes clinical outcomes and therapeutic applications.

Similar Journals

Regenerative Therapy

Advancing regenerative medicine through open access innovation.
Publisher: ELSEVIERISSN: 2352-3204Frequency:

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

BIOCELL

Elevating Scientific Dialogue in Cell Biology
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

Journal of Tissue Engineering and Regenerative Medicine

Bridging engineering and medicine for transformative health.
Publisher: WILEYISSN: 1932-6254Frequency: 12 issues/year

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.

STEM CELLS

Unveiling the potential of stem cell science.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

Regenerative Medicine

Connecting Minds for Revolutionary Health Solutions
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

Journal of Stem Cells & Regenerative Medicine

Connecting Knowledge to Practice in Regenerative Medicine
Publisher: JOURNAL STEM CELLS & REGENERATIVE MEDICINEISSN: 0973-7154Frequency: 2 issues/year

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

CELL AND TISSUE BANKING

Championing impactful research in cell and tissue science.
Publisher: SPRINGERISSN: 1389-9333Frequency: 4 issues/year

CELL AND TISSUE BANKING, published by Springer, is a prominent journal dedicated to advancing the fields of biomaterials, biomedical engineering, cell biology, and transplantation. With its ISSN 1389-9333 and E-ISSN 1573-6814, the journal plays a crucial role in disseminating high-quality research from its inception in 2000 to its ongoing contributions through 2024. Situated in the Netherlands, it boasts a respectable 2023 impact factor with notable quartile rankings, positioning it within the Q3 category for biomaterials, biomedical engineering, and transplantation, and Q4 for cell biology. Furthermore, its Scopus rankings underscore its relevance and influence, particularly in the fields of medicine and engineering. Although it does not currently offer open access options, the journal remains a vital resource for researchers, professionals, and students alike, fostering innovation and knowledge transfer in the critical areas of cell and tissue sustainability.

American Journal of Stem Cells

Advancing regenerative medicine through groundbreaking research.
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-4150Frequency: 1 issue/year

American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.

Frontiers in Bioengineering and Biotechnology

Exploring New Horizons in Bioengineering and Biotechnology
Publisher: FRONTIERS MEDIA SAISSN: 2296-4185Frequency: 1 issue/year

Frontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.

Advanced Biology

Where Cutting-Edge Research Meets Open Access
Publisher: WILEY-V C H VERLAG GMBHISSN: 2701-0198Frequency: 12 issues/year

Advanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.